ARTICLE
20 September 2019

Podcast: DOJ's New Guidance On Evaluating Compliance Programs: What You Need To Know

AG
Akin Gump Strauss Hauer & Feld LLP

Contributor

Akin is a law firm focused on providing extraordinary client service, a rewarding environment for our diverse workforce and exceptional legal representation irrespective of ability to pay. The deep transactional, litigation, regulatory and policy experience we bring to client engagements helps us craft innovative, effective solutions and strategies.
In this episode, Akin Gump health care and life sciences counsel Taylor Jones and Matt Wetzel discuss the Justice Department's recent guidance on evaluation of corporate compliance programs.
United States Corporate/Commercial Law

Subscribe to OnAir with Akin Gump via iTunes, SoundCloud YouTube, Spotify and Google Play.

In this episode, Akin Gump health care and life sciences counsel Taylor Jones and Matt Wetzel discuss the Justice Department's recent guidance on evaluation of corporate compliance programs.

Among the topics covered:

  • Incorporating the guidance into risk assessment.
  • Its impact on the health care sector.
  • What it may reveal about DOJ compliance strategy.
  • Top takeaways.

For more information on Akin Gump's health care and life sciences work, please visit the health care and life sciences page on akingump.com.

Download PDF

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More